Jennifer M Stephens (Jennifer Stephens)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Machine Learning

Chemotherapy Induced

Top Venues

ClinicoEconomics and outcomes research : CEOR

Future oncology (London, England)

Antimicrobial resistance and infection control

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Grace E Fox, Mark Bernauer, Jennifer M Stephens, Bianca Jackson, Joshua A Roth, Ahmed Shelbaya
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Grace E Fox, Mark Bernauer, Jennifer M Stephens, Bianca Jackson, Joshua A Roth, Ahmed Shelbaya
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Paul Cornes, John Kelton, Rongzhe Liu, Omer Zaidi, Jennifer M Stephens, Jingyan Yang
Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia. Future oncology (London, England) (2022)
Justine Alderfer, Jyoti Aggarwal, Kim Gilchrist, Jose Maria Jimenez Alvir, Joseph Cook, Sang Hee Park, Jennifer M Stephens
Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization. ClinicoEconomics and outcomes research : CEOR 14 (2022)
Jingyan Yang, Rongzhe Liu, Anna Granghaud, Omer Zaidi, Jennifer M Stephens
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data. Journal of medical economics 24 (1) (2021)
Dilip Nathwani, Della Varghese, Jennifer M Stephens, Wajeeha Ansari, Stephan Martin, Claudie Charbonneau
Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrobial resistance and infection control 8 (2019)